Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 4.223% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COc1ccc(CN2C(=O)c3ccccc3C2=O)cc1C(=O)Nc1ccc(C)cc1C
b.) CCc1ccc(-c2cc(C)no2)cc1S(=O)(=O)NCCc1ccc(S(N)(=O)=O)cc1
Answer: a. COc1ccc(CN2C(=O)c3ccccc3C2=O)cc1C(=O)Nc1ccc(C)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CN2C(=O)c3ccccc3C2=O)cc1C(=O)Nc1ccc(C)cc1C
COc1ccc(CN2C(=O)c3ccccc3C2=O)cc1C(=O)Nc1ccc(C)cc1C
N-(2,4-dimethylphenyl)-5-[(1,3-dioxoisoindol-2-yl)methyl]-2-methoxybenzamide